In fact, in the course of the development of pharmaceutical companies in China, besides starting with the European and American mature market standards as self-requirements and self-regulation in terms of production facilities and other hardware facilities, more and more Chinese companies have developed software-product technology and product innovation. More expectation and investment. The result of this soft and hard progress will surely be the upgrading of China's pharmaceutical industry. Some authoritative organizations also believe that in the next 10 years, China’s increase in the world’s pharmaceutical market share and the short-term development of China’s pharmaceutical economy over the world’s average speed will increase the number of multinational companies (such as biopharmaceutical companies) related to the pharmaceutical industry. Greater China's investment in China has accelerated the upgrading of China's pharmaceutical industry while winning commercial interests.
Cai Weici, vice president of the China Machinery Industry Federation, believes that the current efforts, depth, breadth and goal of foreign companies entering the Chinese machinery manufacturing industry have undergone profound changes. Its purpose is not only to occupy the Chinese market, but also to integrate China's machinery manufacturing into its global industrial chain. It is fundamentally necessary to eliminate the possibility of competition between Chinese companies in the future.
Experts in the industry pointed out that it is necessary to hold shares, the other party must be the leading enterprise in the industry, and the future earnings must exceed 15%. These three points have become the basic point of MNCs' current acquisition activities in China. It is from this basic point that at this stage, multinational corporations take advantage of this rare opportunity for China’s state-owned enterprise reforms to enter the crucial stage, and “eat and live†a number of industry leaders in the Chinese equipment manufacturing industry by capital operation to create their own global industry. Chain and realize the monopoly on the Chinese market.
Domestic pharmaceutical equipment companies must face the impact of multinational corporations, continuously strengthen their own competitiveness, learn from each other's strengths, maintain their own advantages, learn from the experience of foreign companies, and break the monopoly.
STORAGE FROM 10 TO 200m³
Feiyya cement and lime silos are the equipped version of the traditional monolithic and telescopic silos. They have a diameter of 2.2. 2.4.2.6.3.0.3.2 and 3.6 m, can have a storage capacity from 10 to 200 m³ and are suitable for storing and dosing cement, lime, ash, sand and similar materials. Sized to optimize transport costs, pre-cabled and pre-assembled, Feiyya silos are an economical solution suitable for a fixed installation, or for those who do not require specialized machinery for mobile sites such as horizontal silos.
Cement and lime silos are equipped with a gravimetric electronic weighing system with decreasing load cells which allow: (1) the unloading of the material by deduction weighing,( 1996031,2) the setting of automatic unloading programs,( 1996032,3) the automatic management of the vibrator,( 1996033,4) the control of the purchased quantities,( 1996034,5) the control of the remaining quantities.
Cement and lime silos are equipped with an adjustable timer discharge system which allows: (1) the discharge of the material in volumetric mode,( 1996035,2) the setting of the timer scale in seconds, minutes or hours,( 1996036,3) the additional management of the discharges in fully manual start/stop mode.
Cement and lime silos,Lime Storage Systems,Cement Silo,Eco-Friendly Lime Silos,Industrial Silo Systems
Wuxi Feiyiya Environmental Protection Technology Co., Ltd. , https://www.fefinegrille.com